P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2

被引:81
|
作者
Xirodimas, DP
Chisholm, J
Desterro, JMS
Lane, DP
Hay, RT
机构
[1] Univ St Andrews, Sch Biomed Sci, St Andrews KY16 9TS, Fife, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, Dundee DD1 9SY, Scotland
关键词
(H)Mdm2; p14ARF; SUMO conjugation;
D O I
10.1016/S0014-5793(02)03310-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p14ARF tumour suppressor stabilises and activates p53 by directly interacting with (H)Mdm2 [(human) murine double minute 2 homologue] and inhibiting its E3 ubiquitin ligase activity. Here we demonstrate that p14ARF promotes accumulation of (H)Mdm2 conjugated to the small ubiquitin-like protein SUMO-1. Mutational analysis demonstrated that the N-terminus of Mdm2 is a target for p14ARF-mediated SUMO conjugation. SUMO modification requires residues 2-14 in p14ARF that interact with (H)Mdm2 and residues 82-101 in exon 2 involved in nucleolar localisation of p14ARF. These data suggest a novel role for p14ARF as a regulator of activity of (H)Mdm2, which could be related to its tumour suppressing activities. (C) 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:207 / 211
页数:5
相关论文
共 50 条
  • [31] P14ARF deficiency and its correlation with overexpression of p53/MDM2 in sporadic vestibular schwannomas
    Ying Chen
    Zhao-yan Wang
    Hao Wu
    European Archives of Oto-Rhino-Laryngology, 2015, 272 : 2227 - 2234
  • [32] Study of MDM2 and SUMO-1 expression in actinic cheilitis and lip cancer
    Mônica Ghislaine Oliveira Alves
    Adriana da Mota Delgado
    Ivan Balducci
    Yasmin Rodarte Carvalho
    Ana Sueli Rodrigues Cavalcante
    Janete Dias Almeida
    Archives of Dermatological Research, 2014, 306 : 837 - 841
  • [33] Impact of MDM2, TP53 and P14ARF Polymorphisms on Endometrial Cancer Risk and Onset
    Wujcicka, Wioletta
    Zajac, Agnieszka
    Stachowiak, Grzegorz
    IN VIVO, 2019, 33 (03): : 917 - 924
  • [34] The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9
    Buschmann, T
    Lerner, D
    Lee, CG
    Ronai, Z
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) : 40389 - 40395
  • [35] MDM2与P14ARF在结肠肿瘤中的表达及意义
    郭洁
    沈志祥
    谭诗云
    胃肠病学和肝病学杂志, 2002, (02) : 144 - 146
  • [36] p53 gene status and expression of p53, MDM2, and p14ARF proteins in ameloblastomas
    Kumamoto, H
    Izutsu, T
    Ohki, K
    Takahashi, N
    Ooya, K
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2004, 33 (05) : 292 - 299
  • [37] 卵巢癌p14ARF、mdm2蛋白表达及临床意义
    李博
    曲丹妮
    隋丽华
    哈尔滨医科大学学报, 2007, (05) : 470 - 472
  • [38] Deregulation of the p14ARF/Mdm2/p53 Pathway and G1/S Transition in Two Glioblastoma Sets
    Chiara Ghimenti
    Valentina Fiano
    Loredana Chiadò-Piat
    Adriano Chiò
    Paola Cavalla
    Davide Schiffer
    Journal of Neuro-Oncology, 2003, 61 : 95 - 102
  • [39] Deregulation of the p14ARF/Mdm2/p53 pathway and G1/S transition in two glioblastoma sets
    Ghimenti, C
    Fiano, V
    Chiadò-Piat, L
    Chiò, A
    Cavalla, P
    Schiffer, D
    JOURNAL OF NEURO-ONCOLOGY, 2003, 61 (02) : 95 - 102
  • [40] Correlation of p53, MDM2 and p14ARF protein expression in human esophageal squamous cell carcinoma
    Cheng, Tzu-Hao
    Hsu, Po-Kuei
    Li, Anna Fen-Yau
    Hung, I-Chun
    Huang, Min-Hsiung
    Hsu, Han-Shui
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (11) : 1577 - 1582